Literature DB >> 33662163

A double-blind sham-controlled phase 1 clinical trial of tDCS of the dorsolateral prefrontal cortex in cocaine inpatients: Craving, sleepiness, and contemplation to change.

Pierre-Olivier Gaudreault1, Akarsh Sharma1, Abhishek Datta2, Ester M Nakamura-Palacios3, Sarah King1, Pias Malaker1, Ariella Wagner1, Devarshi Vasa1, Muhammad A Parvaz1, Lucas C Parra4, Nelly Alia-Klein1, Rita Z Goldstein1.   

Abstract

Impaired inhibitory control accompanied by enhanced salience attributed to drug-related cues, both associated with function of the dorsolateral prefrontal cortex (dlPFC), are hallmarks of drug addiction, contributing to worse symptomatology including craving. dlPFC modulation with transcranial direct current stimulation (tDCS) previously showed craving reduction in inpatients with cocaine use disorder (CUD). Our study aimed at assessing feasibility of a longer tDCS protocol in CUD (15 versus the common five/10 sessions) and replicability of previous results. In a randomized double-blind sham-controlled protocol, 17 inpatients with CUD were assigned to either a real-tDCS (right anodal/left cathodal) or a sham-tDCS condition for 15 sessions. Following the previous report, primary outcome measures were self-reported craving, anxiety, depression, and quality of life. Secondary measures included sleepiness, readiness to change drug use, and affect. We also assessed cognitive function including impulsivity. An 88% retention rate demonstrated feasibility. Partially supporting the previous results, there was a trend for self-reported craving to decrease in the real-tDCS group more than the sham-group, an effect that would reach significance with 15 subjects per group. Quality of life and impulsivity improved over time in treatment in both groups. Daytime sleepiness and readiness to change drug use showed significant Group × Time interactions whereby improvements were noted only in the real-tDCS group. One-month follow-up suggested transient effects of tDCS on sleepiness and craving. These preliminary results suggest the need for including more subjects to show a unique effect of real-tDCS on craving and examine the duration of this effect. After replication in larger sample sizes, increased vigilance and motivation to change drug use in the real-tDCS group may suggest fortification of dlPFC-supported executive functions.
© 2021 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  cocaine use disorder; dorsolateral prefrontal cortex; drug addiction; self-reported craving; transcranial direct current stimulation

Mesh:

Substances:

Year:  2021        PMID: 33662163      PMCID: PMC8089045          DOI: 10.1111/ejn.15172

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  97 in total

1.  Delay discounting: I'm a k, you're a k.

Authors:  Amy L Odum
Journal:  J Exp Anal Behav       Date:  2011-11       Impact factor: 2.468

2.  Acute effects of cocaine on the neurobiology of cognitive control.

Authors:  Hugh Garavan; Jacqueline N Kaufman; Robert Hester
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 3.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.

Authors:  N D Volkow; J S Fowler
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

4.  The neural interface between negative emotion regulation and motivation for change in cocaine dependent individuals under treatment.

Authors:  Oren Contreras-Rodríguez; Natalia Albein-Urios; Jose Miguel Martinez-Gonzalez; José Manuel Menchón; Carles Soriano-Mas; Antonio Verdejo-García
Journal:  Drug Alcohol Depend       Date:  2020-01-11       Impact factor: 4.492

5.  Development of the brain's default mode network from wakefulness to slow wave sleep.

Authors:  Philipp G Sämann; Renate Wehrle; David Hoehn; Victor I Spoormaker; Henning Peters; Carolin Tully; Florian Holsboer; Michael Czisch
Journal:  Cereb Cortex       Date:  2011-02-17       Impact factor: 5.357

6.  Cognitive related electrophysiological changes induced by non-invasive cortical electrical stimulation in crack-cocaine addiction.

Authors:  Catarine Lima Conti; Janine Andrade Moscon; Felipe Fregni; Michael Andreas Nitsche; Ester Miyuki Nakamura-Palacios
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-28       Impact factor: 5.176

7.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

8.  Delay and probability discounting by drug-dependent cocaine and marijuana users.

Authors:  Diana Mejía-Cruz; Leonard Green; Joel Myerson; Silvia Morales-Chainé; Javier Nieto
Journal:  Psychopharmacology (Berl)       Date:  2016-05-14       Impact factor: 4.530

9.  Improvement of cognitive control and stabilization of affect by prefrontal transcranial direct current stimulation (tDCS).

Authors:  Ariane Wiegand; Anja Sommer; Vanessa Nieratschker; Christian Plewnia
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

10.  Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study.

Authors:  Alberto Terraneo; Lorenzo Leggio; Marina Saladini; Mario Ermani; Antonello Bonci; Luigi Gallimberti
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-04       Impact factor: 5.415

View more
  2 in total

Review 1.  The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex.

Authors:  Ahmet O Ceceli; Charles W Bradberry; Rita Z Goldstein
Journal:  Neuropsychopharmacology       Date:  2021-08-18       Impact factor: 7.853

2.  Effects of Transcranial Direct Current Stimulation on Attentional Bias to Methamphetamine Cues and Its Association With EEG-Derived Functional Brain Network Topology.

Authors:  Hassan Khajehpour; Muhammad A Parvaz; Mayadeh Kouti; Taherehalsadat Hosseini Rafsanjani; Hamed Ekhtiari; Sepideh Bakht; Alireza Noroozi; Bahador Makkiabadi; Maryam Mahmoodi
Journal:  Int J Neuropsychopharmacol       Date:  2022-08-16       Impact factor: 5.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.